Department of Anesthesiology, Pharmacology & Therapeutics, University of British Columbia, 2176 Health Sciences Mall, Vancouver, BC, V6T 1Z3, Canada.
Department of Psychiatry, University of British Columbia, Vancouver, BC, V6T 1Z3, Canada.
Psychopharmacology (Berl). 2019 Dec;236(12):3385-3399. doi: 10.1007/s00213-019-05298-w. Epub 2019 Jun 22.
Schizophrenia and stimulant-induced psychosis (SIP) represent two different forms of psychotic disorder, with different etiologies. While many of the symptoms of psychosis are common to both disorders, there have been few direct comparisons between these conditions, especially when controlling for stimulant use in individuals with schizophrenia.
We directly compared both psychotic disorders with a comprehensive battery of clinical, neurocognitive and neuroanatomical measures. This included one group with SIP (and concurrent stimulant dependence) and two groups with schizophrenia (either with or without concurrent stimulant dependence).
Ninety-six participants were recruited from a marginalized urban population, which included 39 with SIP (and concurrent stimulant dependence), 18 with schizophrenia (without stimulant dependence), and 39 with schizophrenia (with concurrent stimulant dependence). All subjects had extensive clinical and neurocognitive evaluations, complemented with structural MRI including diffusion tensor imaging (DTI) sequences to determine regional brain volumes and white matter connectivity.
Both positive and negative symptoms were greater in the SZ-dependent group than the other two. Neurocognitive function was broadly similar. The structural brain imaging revealed lateralized changes to the left parietal/temporal lobe, in which regional volumes were smaller in the SZ-dependent than the SZ-non-dependent group. DTI analysis indicated extensive decreases in fractional anisotropy, with parallel increases in radial diffusivity, in the SIP group compared to the SZ-dependent group.
These findings reveal both similarities and differences between SIP and schizophrenia. Furthermore, schizophrenia with concurrent stimulant dependence may be associated with a different clinical and neuroanatomical profile as compared to schizophrenia alone.
精神分裂症和兴奋剂所致精神病(SIP)代表两种不同形式的精神病,其病因不同。虽然精神病的许多症状在两种疾病中都很常见,但这两种疾病之间很少进行直接比较,尤其是在控制精神分裂症患者使用兴奋剂的情况下。
我们使用全面的临床、神经认知和神经解剖学测量方法,直接比较了这两种精神病。其中一组为 SIP(伴有并发兴奋剂依赖),两组为精神分裂症(有或没有并发兴奋剂依赖)。
从一个边缘化的城市人群中招募了 96 名参与者,其中包括 39 名 SIP(伴有并发兴奋剂依赖)、18 名精神分裂症(无兴奋剂依赖)和 39 名精神分裂症(有并发兴奋剂依赖)。所有受试者均进行了广泛的临床和神经认知评估,并辅以结构 MRI,包括弥散张量成像(DTI)序列,以确定区域脑体积和白质连通性。
SIP 依赖组的阳性和阴性症状均大于其他两组。神经认知功能大致相似。结构脑成像显示左侧顶颞叶偏侧化改变,SIP 依赖组的区域体积小于 SZ 非依赖组。与 SZ 依赖组相比,SIP 组的各向异性分数(FA)明显降低,而放射状弥散度(RD)明显增加。
这些发现揭示了 SIP 和精神分裂症之间的异同。此外,与单纯精神分裂症相比,并发兴奋剂依赖的精神分裂症可能与不同的临床和神经解剖学特征相关。